Singular Genomics Systems (OMIC)
(Delayed Data from NSDQ)
$0.32 USD
-0.01 (-1.96%)
Updated Jun 14, 2024 03:58 PM ET
After-Market: $0.32 0.00 (0.00%) 4:48 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
OMIC 0.32 -0.01(-1.96%)
Will OMIC be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for OMIC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OMIC
Similar Genomics Systems (OMIC) Reports Q1 Loss, Lags Revenue Estimates
Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates
OMIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher
Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know
3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1
Other News for OMIC
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
Lab Instrument Industry Update - New Commercial Entrants
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)
Singular Genomics Systems Inc (OMIC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Similar Genomics Systems: Q1 Earnings Snapshot